What convinced 11 of New York's major biomedical institutions to work with you?
New York is a major global biomedical force with unparalleled intellectual resources to support bioscience activities. Yet in the mid-1990s, Boston surpassed New York in NIH [US National Institutes of Health] funding, a gap that continues to widen. New York has also lagged with respect to the development of large-scale, centralized resources in genomics, sequencing and bioinformatics. NIH funding requirements and budgets are also getting tougher and more specific, making it more difficult for an individual investigator or an individual institution to compete at the size and scale required to become a global leader. Today, no one institution can go it alone to compete for funding and make a true transition from basic to translational research. NYGC was developed to meet those challenges head-on, creating an innovative approach to collaboration that would benefit each of the founding institutions while also creating a resource for New York and the world. Ultimately, the members agreed to contribute to NYGC because of the transformative potential for this collaboration.
This is a preview of subscription content, access via your institution